Since the introduction of pharmacologic reperfusion therapy in the seventies, the main goal of reperfusion treatment has been to restore early, full and sustained patency of the infarct related artery . In the seventies and in the eighties,<unk>  therapy was the primary reperfusion strategy that was available for the management of patients with acute ST elevation myocardial infarction (STEMI). An initial analysis consisting of 9 clinical trials by the Fibrinolysis Therapy Trialists (FTT) group demonstrated that there was a significant reduction in the mortality associated with the administration of<unk>  therapy compared to control subjects who did not receive<unk>  therapy (9.6% vs. 11.5%, p<0.00001) .
ST elevation myocardial infarction fibrinolytic therapy
ST elevation myocardial infarction anticoagulant and antithrombotic therapy
ST elevation myocardial infarction reperfusion therapy
ST elevation myocardial infarction aspirin therapy
ST elevation myocardial infarction calcium channel blocker therapy
Unstable angina / non ST elevation myocardial infarction anticoagulant therapy
ST elevation myocardial infarction nitrate therapy
ST elevation myocardial infarction rescue percutaneous coronary intervention